	US 12,433,930 B2
	Powder solid compositions, process for their preparation, formulations and use thereof
Massimo Ronchi, Milan (IT); and Giacomo Mombelli, Milan (IT)
Assigned to INDENA S.P.A., Milan (IT)
Filed by INDENA S.P.A., Milan (IT)
Filed on Jun. 20, 2023, as Appl. No. 18/337,614.
Application 18/337,614 is a division of application No. 16/466,846, granted, now 11,723,942, previously published as PCT/EP2017/080866, filed on Nov. 29, 2017.
Claims priority of application No. 16202405 (EP), filed on Dec. 6, 2016.
Prior Publication US 2023/0330173 A1, Oct. 19, 2023
Int. Cl. A61K 36/752 (2006.01); A23L 33/105 (2016.01); A23P 10/40 (2016.01); A61K 9/14 (2006.01); A61K 9/16 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); A61K 31/7048 (2006.01); A61P 3/06 (2006.01)

CPC A61K 36/752 (2013.01) [A23L 33/105 (2016.08); A23P 10/40 (2016.08); A61K 9/145 (2013.01); A61K 9/1617 (2013.01); A61K 9/1641 (2013.01); A61K 9/1652 (2013.01); A61K 9/1694 (2013.01); A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2054 (2013.01); A61K 9/485 (2013.01); A61K 9/4858 (2013.01); A61K 31/7048 (2013.01); A61P 3/06 (2018.01); A23V 2002/00 (2013.01)]

28 Claims

1. A method of treating metabolic syndromes, dyslipidemias and type 2 diabetes which comprises administering to a patient in need thereof a therapeutically effective amount of a powder solid composition comprising at least one phospholipid and an extract of Bergamot fruit containing neoeriocitrin, naringin and neohesperidin.